Global Dental Drugs Market

Dental Drugs Comprehensive Study by Type (Analgesic, Anesthetics, Antibiotics, Antifungals, Antiseptics, Fluorides, Benzodiazepines, Saliva Substitutes), Mode of Administration (Injectable, Oral, Spray), Distribution Channels (Drug Stores, Retail Pharmacies, Hospital Pharmacies, Online Stores.) Players and Region - Global Market Outlook to 2030

Dental Drugs Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Dental Drugs
Dental Drugs are prescribed medications that used to prevent oral diseases or to control pain and relieve anxiety. Dental Drugs has high growth prospects due to the rising geriatric population, advancement in dental disease diagnostic and treatment technologies. In addition, growing awareness and patient empowerment led to the demand for better healthcare facilities at affordable prices. Factors such as increasing prevalence rate of oral cavity diseases coupled with rising consumer spending on dental restoration solutions and also aesthetics treatments will provide a positive scope for the product penetration during the forecasted timeframe. The major companies are adding more innovative techniques in Asia-Pacific countries as these countries are focused on fastest-growing verticals for the cosmetic industry.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Merck (United States), Bayer (Germany), J&J (United States), GSK (United Kingdom), 3M (United States), Sunstar (Switzerland), Colgate-Palmolive (United States), DenMat (United States), Showa Yakuhin Kako (Japan) and Valeant Pharmaceuticals (Canada) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Septodont (France), Roche (Switzerland), PerioChip (Germany), Hutchison China MediTech (Hong Kong), Xiuzheng Pharmaceutical (China), Acteon (France), Xttrium Laboratorie (United States) and Mediwin Pharmaceuticals (India).

Segmentation Overview
AMA Research has segmented the market of Global Dental Drugs market by Type (Analgesic, Anesthetics, Antibiotics, Antifungals, Antiseptics, Fluorides, Benzodiazepines and Saliva Substitutes) and Region.



On the basis of geography, the market of Dental Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Mode of Administration, the sub-segment i.e. Injectable will boost the Dental Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channels, the sub-segment i.e. Drug Stores will boost the Dental Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
increasing Desires to Retain Natural Teeths.

Market Growth Drivers:
Increasing Rates of Dental Caries and Other Periodontal Infections, Rising Endodontic Cases and Growing Public Awareness about Dental Care

Challenges:
Limited Reimbursement Available for the Treatment and Proliferation of Low-Cost Products

Restraints:
High Cost Associated with Dental Drugs and Lack of Talented Dental Experts

Opportunities:
Rising Number of Dental Clinics., Growing Online Purchase of Oral Hygienic Product and Huge Investments and Increased Interest in Female Population.

Market Leaders and their expansionary development strategies
In January 2023, Sun Pharma acquired three brands from Mumbai based Aksigen Hospital Care to boost anti-inflammatory portfolio and Sun Pharma’s strategy has been a mix of organic and inorganic growth. The company has also been launching new drugs for the domestic and global market.
In January 2o24, Glenmark partners with Pfizer to launched oral drug for atopic dermatitis in India. The prevalence of Atopic Dermatitis has been on the rise over the past three decades with an estimated prevalence of AD of about 10‐20 percent in developed countries.
“According to FDA's Centre of Device and Radiological Health (CDRH) Regulations, it is responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices sold in the United States. In addition, CDRH regulates radiation-emitting electronic products (medical and non-medical) such as lasers, x-ray systems, ultrasound equipment, microwave ovens, and color televisions. It is under this center that dental devices are regulated.”

Key Target Audience
Dental Drugs Manufacturers, Dental Drugs Traders, End-Use Market Participants of Different Segments of Dental Drugs, Government and Research Organizations, R&D Institutions and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Analgesic
  • Anesthetics
  • Antibiotics
  • Antifungals
  • Antiseptics
  • Fluorides
  • Benzodiazepines
  • Saliva Substitutes
By Mode of Administration
  • Injectable
  • Oral
  • Spray

By Distribution Channels
  • Drug Stores
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Stores.

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Rates of Dental Caries and Other Periodontal Infections
      • 3.2.2. Rising Endodontic Cases
      • 3.2.3. Growing Public Awareness about Dental Care
    • 3.3. Market Challenges
      • 3.3.1. Limited Reimbursement Available for the Treatment
      • 3.3.2. Proliferation of Low-Cost Products
    • 3.4. Market Trends
      • 3.4.1. Increasing Desires to Retain Natural Teeths.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dental Drugs, by Type, Mode of Administration, Distribution Channels and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Dental Drugs (Value)
      • 5.2.1. Global Dental Drugs by: Type (Value)
        • 5.2.1.1. Analgesic
        • 5.2.1.2. Anesthetics
        • 5.2.1.3. Antibiotics
        • 5.2.1.4. Antifungals
        • 5.2.1.5. Antiseptics
        • 5.2.1.6. Fluorides
        • 5.2.1.7. Benzodiazepines
        • 5.2.1.8. Saliva Substitutes
      • 5.2.2. Global Dental Drugs by: Mode of Administration (Value)
        • 5.2.2.1. Injectable
        • 5.2.2.2. Oral
        • 5.2.2.3. Spray
      • 5.2.3. Global Dental Drugs by: Distribution Channels (Value)
        • 5.2.3.1. Drug Stores
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Hospital Pharmacies
        • 5.2.3.4. Online Stores.
      • 5.2.4. Global Dental Drugs Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Dental Drugs (Price)
      • 5.3.1. Global Dental Drugs by: Type (Price)
  • 6. Dental Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. J&J (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GSK (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. 3M (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sunstar (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Colgate-Palmolive (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. DenMat (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Showa Yakuhin Kako (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Valeant Pharmaceuticals (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Dental Drugs Sale, by Type, Mode of Administration, Distribution Channels and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Dental Drugs (Value)
      • 7.2.1. Global Dental Drugs by: Type (Value)
        • 7.2.1.1. Analgesic
        • 7.2.1.2. Anesthetics
        • 7.2.1.3. Antibiotics
        • 7.2.1.4. Antifungals
        • 7.2.1.5. Antiseptics
        • 7.2.1.6. Fluorides
        • 7.2.1.7. Benzodiazepines
        • 7.2.1.8. Saliva Substitutes
      • 7.2.2. Global Dental Drugs by: Mode of Administration (Value)
        • 7.2.2.1. Injectable
        • 7.2.2.2. Oral
        • 7.2.2.3. Spray
      • 7.2.3. Global Dental Drugs by: Distribution Channels (Value)
        • 7.2.3.1. Drug Stores
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Hospital Pharmacies
        • 7.2.3.4. Online Stores.
      • 7.2.4. Global Dental Drugs Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Dental Drugs (Price)
      • 7.3.1. Global Dental Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dental Drugs: by Type(USD Million)
  • Table 2. Dental Drugs Analgesic , by Region USD Million (2018-2023)
  • Table 3. Dental Drugs Anesthetics , by Region USD Million (2018-2023)
  • Table 4. Dental Drugs Antibiotics , by Region USD Million (2018-2023)
  • Table 5. Dental Drugs Antifungals , by Region USD Million (2018-2023)
  • Table 6. Dental Drugs Antiseptics , by Region USD Million (2018-2023)
  • Table 7. Dental Drugs Fluorides , by Region USD Million (2018-2023)
  • Table 8. Dental Drugs Benzodiazepines , by Region USD Million (2018-2023)
  • Table 9. Dental Drugs Saliva Substitutes , by Region USD Million (2018-2023)
  • Table 10. Dental Drugs: by Mode of Administration(USD Million)
  • Table 11. Dental Drugs Injectable , by Region USD Million (2018-2023)
  • Table 12. Dental Drugs Oral , by Region USD Million (2018-2023)
  • Table 13. Dental Drugs Spray , by Region USD Million (2018-2023)
  • Table 14. Dental Drugs: by Distribution Channels(USD Million)
  • Table 15. Dental Drugs Drug Stores , by Region USD Million (2018-2023)
  • Table 16. Dental Drugs Retail Pharmacies , by Region USD Million (2018-2023)
  • Table 17. Dental Drugs Hospital Pharmacies , by Region USD Million (2018-2023)
  • Table 18. Dental Drugs Online Stores. , by Region USD Million (2018-2023)
  • Table 19. South America Dental Drugs, by Country USD Million (2018-2023)
  • Table 20. South America Dental Drugs, by Type USD Million (2018-2023)
  • Table 21. South America Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 22. South America Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 23. Brazil Dental Drugs, by Type USD Million (2018-2023)
  • Table 24. Brazil Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 25. Brazil Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 26. Argentina Dental Drugs, by Type USD Million (2018-2023)
  • Table 27. Argentina Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 28. Argentina Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 29. Rest of South America Dental Drugs, by Type USD Million (2018-2023)
  • Table 30. Rest of South America Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 31. Rest of South America Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 32. Asia Pacific Dental Drugs, by Country USD Million (2018-2023)
  • Table 33. Asia Pacific Dental Drugs, by Type USD Million (2018-2023)
  • Table 34. Asia Pacific Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 35. Asia Pacific Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 36. China Dental Drugs, by Type USD Million (2018-2023)
  • Table 37. China Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 38. China Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 39. Japan Dental Drugs, by Type USD Million (2018-2023)
  • Table 40. Japan Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 41. Japan Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 42. India Dental Drugs, by Type USD Million (2018-2023)
  • Table 43. India Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 44. India Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 45. South Korea Dental Drugs, by Type USD Million (2018-2023)
  • Table 46. South Korea Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 47. South Korea Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 48. Taiwan Dental Drugs, by Type USD Million (2018-2023)
  • Table 49. Taiwan Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 50. Taiwan Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 51. Australia Dental Drugs, by Type USD Million (2018-2023)
  • Table 52. Australia Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 53. Australia Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Dental Drugs, by Type USD Million (2018-2023)
  • Table 55. Rest of Asia-Pacific Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 57. Europe Dental Drugs, by Country USD Million (2018-2023)
  • Table 58. Europe Dental Drugs, by Type USD Million (2018-2023)
  • Table 59. Europe Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 60. Europe Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 61. Germany Dental Drugs, by Type USD Million (2018-2023)
  • Table 62. Germany Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 63. Germany Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 64. France Dental Drugs, by Type USD Million (2018-2023)
  • Table 65. France Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 66. France Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 67. Italy Dental Drugs, by Type USD Million (2018-2023)
  • Table 68. Italy Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 69. Italy Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 70. United Kingdom Dental Drugs, by Type USD Million (2018-2023)
  • Table 71. United Kingdom Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 72. United Kingdom Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 73. Netherlands Dental Drugs, by Type USD Million (2018-2023)
  • Table 74. Netherlands Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 75. Netherlands Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 76. Rest of Europe Dental Drugs, by Type USD Million (2018-2023)
  • Table 77. Rest of Europe Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 78. Rest of Europe Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 79. MEA Dental Drugs, by Country USD Million (2018-2023)
  • Table 80. MEA Dental Drugs, by Type USD Million (2018-2023)
  • Table 81. MEA Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 82. MEA Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 83. Middle East Dental Drugs, by Type USD Million (2018-2023)
  • Table 84. Middle East Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 85. Middle East Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 86. Africa Dental Drugs, by Type USD Million (2018-2023)
  • Table 87. Africa Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 88. Africa Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 89. North America Dental Drugs, by Country USD Million (2018-2023)
  • Table 90. North America Dental Drugs, by Type USD Million (2018-2023)
  • Table 91. North America Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 92. North America Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 93. United States Dental Drugs, by Type USD Million (2018-2023)
  • Table 94. United States Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 95. United States Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 96. Canada Dental Drugs, by Type USD Million (2018-2023)
  • Table 97. Canada Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 98. Canada Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 99. Mexico Dental Drugs, by Type USD Million (2018-2023)
  • Table 100. Mexico Dental Drugs, by Mode of Administration USD Million (2018-2023)
  • Table 101. Mexico Dental Drugs, by Distribution Channels USD Million (2018-2023)
  • Table 102. Dental Drugs: by Type(USD/Units)
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Dental Drugs: by Type(USD Million)
  • Table 114. Dental Drugs Analgesic , by Region USD Million (2025-2030)
  • Table 115. Dental Drugs Anesthetics , by Region USD Million (2025-2030)
  • Table 116. Dental Drugs Antibiotics , by Region USD Million (2025-2030)
  • Table 117. Dental Drugs Antifungals , by Region USD Million (2025-2030)
  • Table 118. Dental Drugs Antiseptics , by Region USD Million (2025-2030)
  • Table 119. Dental Drugs Fluorides , by Region USD Million (2025-2030)
  • Table 120. Dental Drugs Benzodiazepines , by Region USD Million (2025-2030)
  • Table 121. Dental Drugs Saliva Substitutes , by Region USD Million (2025-2030)
  • Table 122. Dental Drugs: by Mode of Administration(USD Million)
  • Table 123. Dental Drugs Injectable , by Region USD Million (2025-2030)
  • Table 124. Dental Drugs Oral , by Region USD Million (2025-2030)
  • Table 125. Dental Drugs Spray , by Region USD Million (2025-2030)
  • Table 126. Dental Drugs: by Distribution Channels(USD Million)
  • Table 127. Dental Drugs Drug Stores , by Region USD Million (2025-2030)
  • Table 128. Dental Drugs Retail Pharmacies , by Region USD Million (2025-2030)
  • Table 129. Dental Drugs Hospital Pharmacies , by Region USD Million (2025-2030)
  • Table 130. Dental Drugs Online Stores. , by Region USD Million (2025-2030)
  • Table 131. South America Dental Drugs, by Country USD Million (2025-2030)
  • Table 132. South America Dental Drugs, by Type USD Million (2025-2030)
  • Table 133. South America Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 134. South America Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 135. Brazil Dental Drugs, by Type USD Million (2025-2030)
  • Table 136. Brazil Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 137. Brazil Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 138. Argentina Dental Drugs, by Type USD Million (2025-2030)
  • Table 139. Argentina Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 140. Argentina Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 141. Rest of South America Dental Drugs, by Type USD Million (2025-2030)
  • Table 142. Rest of South America Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 143. Rest of South America Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 144. Asia Pacific Dental Drugs, by Country USD Million (2025-2030)
  • Table 145. Asia Pacific Dental Drugs, by Type USD Million (2025-2030)
  • Table 146. Asia Pacific Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 147. Asia Pacific Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 148. China Dental Drugs, by Type USD Million (2025-2030)
  • Table 149. China Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 150. China Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 151. Japan Dental Drugs, by Type USD Million (2025-2030)
  • Table 152. Japan Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 153. Japan Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 154. India Dental Drugs, by Type USD Million (2025-2030)
  • Table 155. India Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 156. India Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 157. South Korea Dental Drugs, by Type USD Million (2025-2030)
  • Table 158. South Korea Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 159. South Korea Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 160. Taiwan Dental Drugs, by Type USD Million (2025-2030)
  • Table 161. Taiwan Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 162. Taiwan Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 163. Australia Dental Drugs, by Type USD Million (2025-2030)
  • Table 164. Australia Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 165. Australia Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 166. Rest of Asia-Pacific Dental Drugs, by Type USD Million (2025-2030)
  • Table 167. Rest of Asia-Pacific Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 168. Rest of Asia-Pacific Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 169. Europe Dental Drugs, by Country USD Million (2025-2030)
  • Table 170. Europe Dental Drugs, by Type USD Million (2025-2030)
  • Table 171. Europe Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 172. Europe Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 173. Germany Dental Drugs, by Type USD Million (2025-2030)
  • Table 174. Germany Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 175. Germany Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 176. France Dental Drugs, by Type USD Million (2025-2030)
  • Table 177. France Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 178. France Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 179. Italy Dental Drugs, by Type USD Million (2025-2030)
  • Table 180. Italy Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 181. Italy Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 182. United Kingdom Dental Drugs, by Type USD Million (2025-2030)
  • Table 183. United Kingdom Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 184. United Kingdom Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 185. Netherlands Dental Drugs, by Type USD Million (2025-2030)
  • Table 186. Netherlands Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 187. Netherlands Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 188. Rest of Europe Dental Drugs, by Type USD Million (2025-2030)
  • Table 189. Rest of Europe Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 190. Rest of Europe Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 191. MEA Dental Drugs, by Country USD Million (2025-2030)
  • Table 192. MEA Dental Drugs, by Type USD Million (2025-2030)
  • Table 193. MEA Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 194. MEA Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 195. Middle East Dental Drugs, by Type USD Million (2025-2030)
  • Table 196. Middle East Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 197. Middle East Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 198. Africa Dental Drugs, by Type USD Million (2025-2030)
  • Table 199. Africa Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 200. Africa Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 201. North America Dental Drugs, by Country USD Million (2025-2030)
  • Table 202. North America Dental Drugs, by Type USD Million (2025-2030)
  • Table 203. North America Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 204. North America Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 205. United States Dental Drugs, by Type USD Million (2025-2030)
  • Table 206. United States Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 207. United States Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 208. Canada Dental Drugs, by Type USD Million (2025-2030)
  • Table 209. Canada Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 210. Canada Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 211. Mexico Dental Drugs, by Type USD Million (2025-2030)
  • Table 212. Mexico Dental Drugs, by Mode of Administration USD Million (2025-2030)
  • Table 213. Mexico Dental Drugs, by Distribution Channels USD Million (2025-2030)
  • Table 214. Dental Drugs: by Type(USD/Units)
  • Table 215. Research Programs/Design for This Report
  • Table 216. Key Data Information from Secondary Sources
  • Table 217. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dental Drugs: by Type USD Million (2018-2023)
  • Figure 5. Global Dental Drugs: by Mode of Administration USD Million (2018-2023)
  • Figure 6. Global Dental Drugs: by Distribution Channels USD Million (2018-2023)
  • Figure 7. South America Dental Drugs Share (%), by Country
  • Figure 8. Asia Pacific Dental Drugs Share (%), by Country
  • Figure 9. Europe Dental Drugs Share (%), by Country
  • Figure 10. MEA Dental Drugs Share (%), by Country
  • Figure 11. North America Dental Drugs Share (%), by Country
  • Figure 12. Global Dental Drugs: by Type USD/Units (2018-2023)
  • Figure 13. Global Dental Drugs share by Players 2023 (%)
  • Figure 14. Global Dental Drugs share by Players (Top 3) 2023(%)
  • Figure 15. Global Dental Drugs share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 18. Merck (United States) Revenue: by Geography 2023
  • Figure 19. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Bayer (Germany) Revenue: by Geography 2023
  • Figure 21. J&J (United States) Revenue, Net Income and Gross profit
  • Figure 22. J&J (United States) Revenue: by Geography 2023
  • Figure 23. GSK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. GSK (United Kingdom) Revenue: by Geography 2023
  • Figure 25. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 26. 3M (United States) Revenue: by Geography 2023
  • Figure 27. Sunstar (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Sunstar (Switzerland) Revenue: by Geography 2023
  • Figure 29. Colgate-Palmolive (United States) Revenue, Net Income and Gross profit
  • Figure 30. Colgate-Palmolive (United States) Revenue: by Geography 2023
  • Figure 31. DenMat (United States) Revenue, Net Income and Gross profit
  • Figure 32. DenMat (United States) Revenue: by Geography 2023
  • Figure 33. Showa Yakuhin Kako (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Showa Yakuhin Kako (Japan) Revenue: by Geography 2023
  • Figure 35. Valeant Pharmaceuticals (Canada) Revenue, Net Income and Gross profit
  • Figure 36. Valeant Pharmaceuticals (Canada) Revenue: by Geography 2023
  • Figure 37. Global Dental Drugs: by Type USD Million (2025-2030)
  • Figure 38. Global Dental Drugs: by Mode of Administration USD Million (2025-2030)
  • Figure 39. Global Dental Drugs: by Distribution Channels USD Million (2025-2030)
  • Figure 40. South America Dental Drugs Share (%), by Country
  • Figure 41. Asia Pacific Dental Drugs Share (%), by Country
  • Figure 42. Europe Dental Drugs Share (%), by Country
  • Figure 43. MEA Dental Drugs Share (%), by Country
  • Figure 44. North America Dental Drugs Share (%), by Country
  • Figure 45. Global Dental Drugs: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Merck (United States)
  • Bayer (Germany)
  • J&J (United States)
  • GSK (United Kingdom)
  • 3M (United States)
  • Sunstar (Switzerland)
  • Colgate-Palmolive (United States)
  • DenMat (United States)
  • Showa Yakuhin Kako (Japan)
  • Valeant Pharmaceuticals (Canada)
Additional players considered in the study are as follows:
Septodont (France) , Roche (Switzerland) , PerioChip (Germany) , Hutchison China MediTech (Hong Kong) , Xiuzheng Pharmaceutical (China) , Acteon (France) , Xttrium Laboratorie (United States) , Mediwin Pharmaceuticals (India)
Select User Access Type

Key Highlights of Report


Mar 2024 230 Pages 79 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Dental Drugs Market Quantitative research analysis
Global Dental Drugs Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Merck (United States), Bayer (Germany), J&J (United States), GSK (United Kingdom), 3M (United States), Sunstar (Switzerland), Colgate-Palmolive (United States), DenMat (United States), Showa Yakuhin Kako (Japan) and Valeant Pharmaceuticals (Canada) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"increasing Desires to Retain Natural Teeths." is seen as one of major influencing trends for Dental Drugs Market during projected period 2023-2030.
The Dental Drugs market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Dental Drugs Market Report?

Have a Query? Click Here

Other Related Reports

Clarityne Comprehensive Study by Type (Loratadine Tablet, Loratadine Capsule, Loratadine Syrup), Application (Adult Drug, Pediatric Drug), Sales Channel (Hospitals, Drug Store, Specialty Pharmacy, E-...
$ 3500
General Anesthesia Drugs Comprehensive Study by Type (Propofol, Dexmedetomidine, Sevoflurane, Desflurane, Midazolam, Others), Application (Inhalational Anesthetics, Intravenous Anesthetics), Distribu...
$ 3650
Zinc Gluconate Comprehensive Study by Application (Food, Pharmaceutical, Feed, Other), Distribution Channels (Online Pharmacies, Medical Stores, Hospital Pharmacies, Others), Dosage Form (Tablets, In...
$ 3650
Zoster Vaccine Comprehensive Study by Type (Live Vaccines, Attenuated Vaccines), Application (Herpes Zoster, Others), End Users (Hospitals, Clinic, Others) Players and Region - Global Market Outlook ...
$ 3500
Corticosteroids Comprehensive Study by Type (Glucocorticoids, Mineralocorticoids), Application (Hospital, Clinic, Others), Route of Administration (Oral, Intravenous, Topical/Enema), Form (Capsules, ...
$ 3350
Chlorhexidine Gluconate Comprehensive Study by Type (CHG 2% Solution, CHG 4% Solution, CHG 20% Solution, CHG 0.12% Solution, Others), Application (Skin Preparation, Surgical Preparation, Pharmaceutic...
$ 3750